OHK Medical Devices

hemaclear.com

OHK Medical Devices, Inc. develops and manufactures surgical tourniquets under the HemaClear brand (www.hemaclear.com). HemaClear helps prepare patients for any orthopedic procedure in just 12 seconds. With more than 500,000 procedures performed to date, the tourniquet is becoming a standard of care in operating rooms in many countries. It is regularly used in leading hospitals such as The Hospital for Special Surgery in New York, Sinai Hospital of Baltimore, and the Shriners Hospitals for Children.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

GINKGO BIOWORKS AND NOVO NORDISK TO COLLABORATE ON EXPRESSION SYSTEMS FOR PHARMACEUTICAL PRODUCTS

Ginkgo Bioworks and Novo Nordisk, | June 08, 2022

news image

Ginkgo Bioworks the leading horizontal platform for cell programming, announced a collaboration with Novo Nordisk, a leading global healthcare company, to create novel expression hosts for pharmaceutical products. hundreds of millions of people are living with diabetes, obesity, and other serious chronic diseases, putting a strain on individuals, families, and healthcare systems. More effective medicines could improve treatment options for these people. Using synthetic biology, Gi...

Read More

NURO’S SELF-DRIVING VEHICLES TO DELIVER PRESCRIPTIONS FOR CVS PHARMACY

Techcrunch | May 28, 2020

news image

Nuro, the autonomous robotics startup that has raised more than $1 billion from SoftBank Vision Fund, Greylock and other investors, said Thursday it will test prescription delivery in Houston through a partnership with CVS Pharmacy. The pilot, which will use a fleet of the startup’s autonomous Toyota Prius vehicles and transition to using its custom-built R2 delivery bots, is slated to begin in June. The partnership marks Nuro’s expansion beyond groceries and into healthcare. L...

Read More

OPEN ORPHAN SECURES STUDY TRIAL CONTRACT WITH MYSTERY PHARMACEUTICAL COMPANY

Open Orphan | August 10, 2020

news image

Pharmaceutical services company Open Orphan has scored a £4.0m contract with an unnamed top-three global pharmaceutical company to be the sponsor of and provide a respiratory syncytial virus human challenge study trial. Open Orphan said the new contract represented the continued conversion of its substantial pipeline and generation of significant cash flow. The AIM-listed group added that the study would take place in subsidiary hVIVO's London-based quarantine unit and was expected to ...

Read More

Pharma Tech

AQUAVIT FURTHER PREVAILS AGAINST COUNTERFEITERS IN U S FOLLOWING ITS RECENT VICTORY IN EUROPE

Aquavit Pharmaceuticals, Inc | March 22, 2022

news image

Aquavit Pharmaceuticals, Inc continues to succeed in its intellectual property cases against counterfeiters both domestically and abroad. Following a recent win against counterfeiter U-BioMed, Inc. across the European Union, the U.S. Southern District Court of New York adopted Judge Lehrburger's recommendations that any sanctions related to U-BioMed's deletion of its Instagram account, which blatantly exploited Aquavit's AQUAGOLD product illegally, be folded into the p...

Read More
news image

Business Insights

GINKGO BIOWORKS AND NOVO NORDISK TO COLLABORATE ON EXPRESSION SYSTEMS FOR PHARMACEUTICAL PRODUCTS

Ginkgo Bioworks and Novo Nordisk, | June 08, 2022

Ginkgo Bioworks the leading horizontal platform for cell programming, announced a collaboration with Novo Nordisk, a leading global healthcare company, to create novel expression hosts for pharmaceutical products. hundreds of millions of people are living with diabetes, obesity, and other serious chronic diseases, putting a strain on individuals, families, and healthcare systems. More effective medicines could improve treatment options for these people. Using synthetic biology, Gi...

Read More
news image

NURO’S SELF-DRIVING VEHICLES TO DELIVER PRESCRIPTIONS FOR CVS PHARMACY

Techcrunch | May 28, 2020

Nuro, the autonomous robotics startup that has raised more than $1 billion from SoftBank Vision Fund, Greylock and other investors, said Thursday it will test prescription delivery in Houston through a partnership with CVS Pharmacy. The pilot, which will use a fleet of the startup’s autonomous Toyota Prius vehicles and transition to using its custom-built R2 delivery bots, is slated to begin in June. The partnership marks Nuro’s expansion beyond groceries and into healthcare. L...

Read More
news image

OPEN ORPHAN SECURES STUDY TRIAL CONTRACT WITH MYSTERY PHARMACEUTICAL COMPANY

Open Orphan | August 10, 2020

Pharmaceutical services company Open Orphan has scored a £4.0m contract with an unnamed top-three global pharmaceutical company to be the sponsor of and provide a respiratory syncytial virus human challenge study trial. Open Orphan said the new contract represented the continued conversion of its substantial pipeline and generation of significant cash flow. The AIM-listed group added that the study would take place in subsidiary hVIVO's London-based quarantine unit and was expected to ...

Read More
news image

Pharma Tech

AQUAVIT FURTHER PREVAILS AGAINST COUNTERFEITERS IN U S FOLLOWING ITS RECENT VICTORY IN EUROPE

Aquavit Pharmaceuticals, Inc | March 22, 2022

Aquavit Pharmaceuticals, Inc continues to succeed in its intellectual property cases against counterfeiters both domestically and abroad. Following a recent win against counterfeiter U-BioMed, Inc. across the European Union, the U.S. Southern District Court of New York adopted Judge Lehrburger's recommendations that any sanctions related to U-BioMed's deletion of its Instagram account, which blatantly exploited Aquavit's AQUAGOLD product illegally, be folded into the p...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us